[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-396117-105":59,"doc-detail-396117-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","practice-guideline-for-the-treatment-of-patients-with-obsessive-compulsive-disorder-read-online","Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder - read online","","Practice guideline for the treatment of patients with obsessive-compulsive disorder (OCD) outlining clinical recommendations and the development process. Approved October 2006 and published July 2007, it presents an executive summary, coding system, and structured guidance for psychiatric management, initial treatment modality selection, pharmacological options, and psychotherapy forms. The document emphasizes therapeutic alliance, symptom assessment, use of rating scales, safety evaluation, treatment goals, adherence, implementation steps, and discontinuation of active treatment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/practice-guideline-for-the-treatment-of-patients-with-obsessive-compulsive-disorder-read-online/396117/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/practice-guideline-for-the-treatment-of-patients-with-obsessive-compulsive-disorder-read-online/396117.png","ImageObject",300,407,{"name":92,"@type":93},"8796093062539","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-26",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"When was this OCD practice guideline approved and published?","Question",{"text":113,"@type":114},"It was approved in October 2006 and published in July 2007.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What topics are included in the executive summary section?",{"text":118,"@type":114},"The executive summary covers a coding system and key elements of psychiatric management, including establishing a therapeutic alliance, assessing symptoms, using rating scales, improving safety, completing assessment, setting treatment goals, choosing the treatment setting, enhancing adherence, selecting initial treatment modality, pharmacological treatment, and psychotherapy forms.",{"name":120,"@type":111,"acceptedAnswer":121},"What does the guideline focus on for implementing a treatment plan?",{"text":122,"@type":114},"It provides steps for implementing the plan, including implementing pharmacotherapy, cognitive-behavioral therapies, and adjusting treatments through sequential treatment trials, as well as guidance on discontinuing active treatment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},396117,1790740153,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},8796093062539,"PRACTICE GUIDELINE FOR THE Treatment of Patients With Obsessive-Compulsive Disorder  \nWORK GROUP ON OBSESSIVE-COMPULSIVE DISORDER  \nLorrin M. Koran, M.D., Chair  \nGregory L. Hanna, M.D.  \nEric Hollander, M.D.  \nGerald Nestadt, M.D.  \nHelen Blair Simpson, M.D., Ph.D.  \nThis practice guideline was approved in October 2006 and published in July 2007.  \nA guideline watch, summarizing significant developments in the scientific literature since publication of this guideline, may be available in the Psychiatric Practice section of the American Psychiatric Association (APA) Web site at [www.psych.org](www.psych.org).  \nDr. Koran has received research grants from Forest Pharmaceuticals, Pfizer, Eli Lilly, Ortho-McNeil, Somaxon, and Jazz Pharmaceuticals. He has received honoraria from the Forest Pharmaceuticals Speakers Bureau and the Pfizer Speakers Bureau. He has received consultant fees from Cypress Bioscience. Dr. Hanna reports no competing interests. Dr. Hollander has received research grants from the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Drug Abuse, the Office of Orphan Products Development of the U.S. Food and Drug Administration, Pfizer, GlaxoSmithKline, Wyeth, Eli Lilly, Janssen, and Abbott. He has served on advisory boards for Forest Pharmaceuticals, Abbott, and Somaxon. Dr. Nestadt reports no competing interests. Dr. Simpson reports no competing interests. The Executive Committee on Practice Guidelines has reviewed this guideline and found no evidence of influence from these relationships.  \nSuggested citation: American Psychiatric Association . Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington, VA: American Psychiatric Association, 2007. Available online at [http//www.psych.org/psych_pract/treatg/pg/](http//www.psych.org/psych_pract/treatg/pg/)[ ](http//www.psych.org/psych_pract/treatg/pg/)[prac_ guide.cfm.](prac_ guide.cfm.)  \nAMERICAN PSYCHIATRIC ASSOCIATION  \nSTEERING COMMITTEE ON PRACTICE GUIDELINES  \nJohn S. McIntyre, M.D., Chair  \nSara C. Charles, M.D., Vice-Chair  \nDaniel J. Anzia, M.D.  \nIan A. Cook, M.D.  \nMolly T. Finnerty, M.D.  \nBradley R. Johnson, M.D.  \nJames E. Nininger, M.D.  \nPaul Summergrad, M.D.  \nSherwyn M. Woods, M.D., Ph.D.  \nJoel Yager, M.D.  \nAREA AND COMPONENT LIAISONS  \nJoseph Berger, M.D. (Area I)  \nC. Deborah Cross, M.D. (Area II)  \nHarry A. Brandt, M.D. (Area III)  \nPhilip M. Margolis, M.D. (Area IV)  \nJohn P. D. Shemo, M.D. (Area V)  \nBarton J. Blinder, M.D. (Area VI)  \nDavid L. Duncan, M.D. (Area VII)  \nMary Ann Barnovitz, M.D.  \nSheila Hafter Gray, M.D.  \nSunil Saxena, M.D.  \nTina Tonnu, M.D.  \nSTAFF  \nRobert Kunkle, M.A., Senior Program Manager  \nAmy B. Albert, B.A., Project Manager  \nThomas J. Craig, M.D., M.P.H., Director, Department of Quality Improvement and Psychiatric Services  \nDarrel A. Regier, M.D., M.P.H., Director, Division of Research  \nMEDICAL EDITOR  \nLaura J. Fochtmann, M.D.  \nCONTENTS  \nSTATEMENT OF INTENT .................................................................... 7  \nGUIDE TO USING THIS PRACTICE GUIDELINE ...................................................... 7  \nDEVELOPMENT PROCESS ................................................................... 8  \nPART A: TREATMENT RECOMMENDATIONS ......................................... 9  \nI. EXECUTIVE SUMMARY ............................................................... 9  \nA. Coding System ................................................................ 9  \nB. Executive Summary ............................................................ 9  \n1. Psychiatric Management .............................................................. 9  \na. Establishing a Therapeutic Alliance .................................................. 9  \nb. Assessing the Patient’s Symptoms .................................................. 9  \nc. Using Rating Scales .......................................................","cbCailbyqehbekaQ","https://ap.wps.com/l/cbCailbyqehbekaQ","pdf",1392859,96,"English","# Statement of Intent\n# Guide to Using This Practice Guideline\n# Development Process\n# Part A: Treatment Recommendations\n## I. Executive Summary\n## II. Formulation and Implementation of a Treatment Plan","[{\"question\":\"When was this OCD practice guideline approved and published?\",\"answer\":\"It was approved in October 2006 and published in July 2007.\"},{\"question\":\"What topics are included in the executive summary section?\",\"answer\":\"The executive summary covers a coding system and key elements of psychiatric management, including establishing a therapeutic alliance, assessing symptoms, using rating scales, improving safety, completing assessment, setting treatment goals, choosing the treatment setting, enhancing adherence, selecting initial treatment modality, pharmacological treatment, and psychotherapy forms.\"},{\"question\":\"What does the guideline focus on for implementing a treatment plan?\",\"answer\":\"It provides steps for implementing the plan, including implementing pharmacotherapy, cognitive-behavioral therapies, and adjusting treatments through sequential treatment trials, as well as guidance on discontinuing active treatment.\"}]","Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder - read online | PDF",1790429876,242]